Clinical Trial Update: Amniotic Fluid Tandem Mass Spectrometry for Pregnancies Complicated by NIH and Severe Symmetrical IUGR

View source ↗

Summary

The trial assessing amniotic fluid tandem mass spectrometry for pregnancies with hydrops fetalis and fetal growth restriction has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fetal Growth Restriction
• Hydrops Fetalis

Snippet

Sponsor: Obstetrix Medical Group | Conditions: Hydrops Fetalis, Fetal Growth Retardation | Status: TERMINATED